These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18445995)

  • 21. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
    Brandi G; Rizzo A; Deserti M; Relli V; Indio V; Bin S; Pariali M; Palloni A; De Lorenzo S; Tovoli F; Tavolari S
    BMC Med Genet; 2020 Nov; 21(1):225. PubMed ID: 33208122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCC2 haplotype is not associated with drug-resistant epilepsy.
    Seo T; Ishitsu T; Oniki K; Abe T; Shuto T; Nakagawa K
    J Pharm Pharmacol; 2008 May; 60(5):631-5. PubMed ID: 18416940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.
    Rau T; Erney B; Göres R; Eschenhagen T; Beck J; Langer T
    Clin Pharmacol Ther; 2006 Nov; 80(5):468-76. PubMed ID: 17112803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
    Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y
    J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28.
    Itoda M; Saito Y; Soyama A; Saeki M; Murayama N; Ishida S; Sai K; Nagano M; Suzuki H; Sugiyama Y; Ozawa S; Sawada Ji J
    Drug Metab Dispos; 2002 Apr; 30(4):363-4. PubMed ID: 11901087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese.
    Fukushima-Uesaka H; Saito Y; Maekawa K; Kamatani N; Kajio H; Kuzuya N; Noda M; Yasuda K; Sawada J
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):212-9. PubMed ID: 17603223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American.
    Kaniwa N; Kurose K; Jinno H; Tanaka-Kagawa T; Saito Y; Saeki M; Sawada J; Tohkin M; Hasegawa R
    Drug Metab Dispos; 2005 Mar; 33(3):458-65. PubMed ID: 15572581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects.
    Cao K; Ren G; Lu C; Wang Y; Tan Y; Zhou J; Zhang Y; Lu Y; Li N; Chen X; Zhao D
    Eur J Clin Pharmacol; 2020 Jan; 76(1):51-59. PubMed ID: 31677118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences.
    Maekawa K; Saeki M; Saito Y; Ozawa S; Kurose K; Kaniwa N; Kawamoto M; Kamatani N; Kato K; Hamaguchi T; Yamada Y; Shirao K; Shimada Y; Muto M; Doi T; Ohtsu A; Yoshida T; Matsumura Y; Saijo N; Sawada JI
    J Hum Genet; 2007; 52(10):804-819. PubMed ID: 17828463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients.
    Brazeau D; Meaney CJ; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
    J Clin Pharmacol; 2021 Dec; 61(12):1592-1605. PubMed ID: 34169529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.
    Kim WJ; Lee JH; Yi J; Cho YJ; Heo K; Lee SH; Kim SW; Kim MK; Kim KH; In Lee B; Lee MG
    Pharmacogenet Genomics; 2010 Apr; 20(4):249-56. PubMed ID: 20216337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.
    Becker ML; Elens LL; Visser LE; Hofman A; Uitterlinden AG; van Schaik RH; Stricker BH
    Pharmacogenomics J; 2013 Jun; 13(3):251-6. PubMed ID: 22186618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
    Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
    Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.
    Maekawa K; Itoda M; Sai K; Saito Y; Kaniwa N; Shirao K; Hamaguchi T; Kunitoh H; Yamamoto N; Tamura T; Minami H; Kubota K; Ohtsu A; Yoshida T; Saijo N; Kamatani N; Ozawa S; Sawada J
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):109-21. PubMed ID: 16702730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib.
    Wei D; Zhang H; Peng R; Huang C; Bai R
    Xenobiotica; 2017 Nov; 47(11):1008-1014. PubMed ID: 27855531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese population.
    Saito Y; Yamamoto N; Katori N; Maekawa K; Fukushima-Uesaka H; Sugimoto D; Kurose K; Sai K; Kaniwa N; Sawada J; Kunitoh H; Ohe Y; Yoshida T; Matsumura Y; Saijo N; Okuda H; Tamura T
    Drug Metab Pharmacokinet; 2011; 26(1):107-16. PubMed ID: 21084761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.
    Rädisch S; Dickens D; Lang T; Bonnett L; Arlanov R; Johnson MR; Schwab M; Marson AG; Pirmohamed M
    Pharmacogenomics J; 2014 Oct; 14(5):481-7. PubMed ID: 24567120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.
    Wen X; Joy MS; Aleksunes LM
    Pharm Res; 2017 Aug; 34(8):1637-1647. PubMed ID: 28405913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.